Navigation Links
Data from Jazz Pharmaceuticals' First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia to be Presented at Upcoming Conferences
Date:10/14/2009

PALO ALTO, Calif., Oct. 14 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) announced today that data from the company's first Phase III clinical trial of sodium oxybate (JZP-6) for the treatment of fibromyalgia will be presented next week during the American College of Rheumatology 2009 Annual Meeting (ACR) in Philadelphia, Pennsylvania and also in November during the US Psychiatric and Mental Health Congress (US Psych Congress) in Las Vegas, Nevada.

  • At ACR on October 20, 2009, I. Jon Russell, MD, PhD, Associate Professor of Medicine in the Division of Clinical Immunology and Rheumatology and Director, University Clinical Research Center at The University of Texas Health Science Center at San Antonio, will present a poster entitled, "Effect of Sodium Oxybate on Pain, Functionality, PGIc, & Composite Scores in Fibromyalgia - Results from a Phase 3 Controlled Trial". The poster will be presented in the 9:00 am - 11:00 am poster session.
  • Also at ACR on October 20, 2009, Philip J. Mease, MD, Clinical Professor at the University of Washington School of Medicine in Seattle and Chief of Rheumatology Clinical Research at the Swedish Hospital Medical Center, will present a poster entitled, "Sodium Oxybate Improves Fatigue, Sleep Disturbance, and PGIc in Fibromyalgia - Results from a Phase 3, 14-Week Controlled Trial". The poster will be presented in the 9:00 am - 11:00 am poster session.
  • At US Psych Congress on November 2, 2009, Stephen S. Flitman, MD, Medical Director at 21st Century Neurology, a division of Xenoscience, will present a poster entitled, "Efficacy and Safety of Sodium Oxybate in Fibromyalgia: A 14-week, Randomized, Double-blind, Controlled Trial". The poster will be presented in the 3:45 pm - 6:45 pm poster session.

Jazz Pharmaceuticals has completed two Phase III
'/>"/>

SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Timm Medical Technologies and Ferring Pharmaceuticals Enter Exclusive Co-Promotion Agreement for Prosed(R) DS
2. China Yongxin Pharmaceuticals Inc. Announces Second Quarter 2009 Financial Results
3. VIA Pharmaceuticals Receives Favorable Hearing Decision From NASDAQ
4. Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt(TM) in the U.S. and Canada for the Treatment of Schizophrenia
5. Vion Pharmaceuticals Engages Merriman Curhan Ford to Evaluate Strategic Alternatives
6. Arena Pharmaceuticals Lorcaserin to be Featured in Multiple Presentations at Obesity 2009
7. Onyx Pharmaceuticals to Acquire Proteolix, Inc.
8. Onyx Pharmaceuticals Announces Investor Teleconference and Webcast
9. ADVENTRX Pharmaceuticals Announces Closing of Financing
10. Savient Pharmaceuticals Prices Underwritten Offering of Common Stock
11. Endo Pharmaceuticals to Announce Third Quarter 2009 Financial Results on October 29, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... PROSPECT, Ill. , June 18, 2013 /PRNewswire-iReach/ ... of its new X3130 Appliance Inlet Module. The ... circuit breaker , combines a C14 appliance inlet ... one compact package.  This three-in-one device allows design ... their designs - cutting installation time by 66 ...
(Date:6/18/2013)... PARSIPPANY, N.J. , June 18, 2013  Actavis, Inc. ... ("New Actavis") has filed with the U.S. Securities and Exchange ... with Actavis, proposed acquisition of Warner Chilcott plc ... statement of Actavis and Warner Chilcott (the "Form ... Actavis and Warner Chilcott have entered into a ...
(Date:6/18/2013)... 2013  It has become apparent that a ... Mobility, a subsidiary company of The Scooter Store, ... appears to be due to the ongoing bankruptcy ... employees.  (Logo: http://photos.prnewswire.com/prnh/20130402/CG87448LOGO ) ... clients are complex mobility users with significant disabilities, ...
Breaking Medicine Technology:Three-in-One X3130 Appliance Inlet Module 2Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 2Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 3Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 4Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 5Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 6Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 7
(Date:6/18/2013)... ENT and Allergy Associates, LLP (ENTA) does not ... , New York/New Jersey’s premier ear, nose, throat, ... offering superior healthcare to children and adults in hundreds ... York area-only considers adding to its current footprint when ... the right communities to serve, the right locations from ...
(Date:6/18/2013)... 2013 Palo Alto has taken yet another ... cities with its recent major long-term solar power commitment. ... solar electric power purchase agreements , which together will result ... solar photovoltaic electric power per year, which is the equivalent ... That’s enough power to supply all 65,000+ Palo Alto residents---and ...
(Date:6/18/2013)... Biomet hip lawsuit claims involving ... a multidistrict litigation in U.S. District Court, Northern District ... court records, the litigation’s most recent status conference was ... also convened a motions hearing and a tutorial on ... hip replacement litigation. The proceeding’s next Status Conference ...
(Date:6/18/2013)... Sun Buick GMC, Moosic, is sponsoring the hole-in-one contest at ... on Thursday, June 20, at Irem Country Club, Dallas, Pennsylvania. ... Verano and will go to the lucky golfer at the ... , The MFHS golf tournament is open to all interested ... crew team for 18 holes. The fee is $125 per ...
(Date:6/18/2013)... June 18, 2013 Seven-year-old Riley Salz ... from autism. He receives 40 hours a week of ... shadowing) from the Center for Autism and Related Disorders ... August, 2008, and has experienced remarkable progress, including learning ... his environment. Riley’s personal journey through autism is now ...
Breaking Medicine News(10 mins):Health News:ENT and Allergy Associates Merges with Hudson Valley ENT, Adds Five Superb Physicians, Expands Overall County Presence 2Health News:ENT and Allergy Associates Merges with Hudson Valley ENT, Adds Five Superb Physicians, Expands Overall County Presence 3Health News:ENT and Allergy Associates Merges with Hudson Valley ENT, Adds Five Superb Physicians, Expands Overall County Presence 4Health News:ENT and Allergy Associates Merges with Hudson Valley ENT, Adds Five Superb Physicians, Expands Overall County Presence 5Health News:Palo Alto Seals the Deal on Major Solar Electric Investments 2Health News:Palo Alto Seals the Deal on Major Solar Electric Investments 3Health News:Biomet Hip Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Biomet Hip Replacement Litigation 2Health News:Biomet Hip Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Biomet Hip Replacement Litigation 3Health News:June's Release of CARD's "Mission Possible: Portraits of Hope" Features Southern California Child and His Remarkable Progress with Intensive Autism Therapy 2Health News:June's Release of CARD's "Mission Possible: Portraits of Hope" Features Southern California Child and His Remarkable Progress with Intensive Autism Therapy 3
... Coordinating and timing,activities is a top challenge that ... landmark clinical trials. Best-in-class,companies understand that successfully communicating ... findings are available. Successful,communication depends on early actions ... of breakthrough molecules in development -- Early ...
... UK and PHILADELPHIA, US June 17 ,Shire Limited ... today announced the publication of data from a,randomized, ... colitis (UC) drug Lialda(TM) (mesalamine). The primary endpoints,of ... tolerability of Lialda in,mild-to-moderate UC patients over 12 ...
... on octopuses has shed new light on how our ... of the Department of Neurobiology at the Alexander Silberman ... Jerusalem., Why octopuses?, Octopuses and other related creatures, known ... invertebrates because they have relatively large brains and they ...
... second it takes an ambulance to get to its ... driving faster, can ambulances get emergency services to people ... a classic operations research question that three Cornell researchers ... Foundation grant of almost $300,000 is allowing associate professor ...
... Europe,s position as a major player in genome ... Foundation,s three-year EUROCORES programme EuroDYNA. As it draws ... Chromatin Function) is leaving behind a healthy European ... the structure of the cellular nucleus and mechanisms ...
... tumor hypoglycemia (NICTH) is a rare association between ... than the pancreatic islets. It was initially associated ... types have been described. , The pathogenesis ... of mechanisms, including excessive consumption of glucose by ...
Cached Medicine News:Health News:Long-Term Safety Data on Lialda(TM) (mesalamine) for Patients With Ulcerative Colitis Published in Leading GI Journal 2Health News:Long-Term Safety Data on Lialda(TM) (mesalamine) for Patients With Ulcerative Colitis Published in Leading GI Journal 3Health News:Long-Term Safety Data on Lialda(TM) (mesalamine) for Patients With Ulcerative Colitis Published in Leading GI Journal 4Health News:Long-Term Safety Data on Lialda(TM) (mesalamine) for Patients With Ulcerative Colitis Published in Leading GI Journal 5Health News:Long-Term Safety Data on Lialda(TM) (mesalamine) for Patients With Ulcerative Colitis Published in Leading GI Journal 6Health News:Hebrew University research on octopuses sheds light on memory 2Health News:Hebrew University research on octopuses sheds light on memory 3Health News:Cornell efficiency experts seek to save precious minutes in deploying ambulances 2Health News:EuroDYNA leaves healthy genomic research ecosystem as legacy 2Health News:EuroDYNA leaves healthy genomic research ecosystem as legacy 3
Khosla Precision and Quality in Medical and Surgical Products....
Manual Table For Slit Lamp...
Khosla Precision and Quality in Medical and Surgical Products....
...
Medicine Products: